Xeno START
Business Services · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.xenostart.comRevenue
<$5 MillionIndustry
About Xeno START
The START Center for Cancer Research is a global leader in cancer research, dedicated to advancing oncology treatments through its preclinical business, XenoSTART. They offer an extensive collection of over 2,500 high-quality patient-derived xenograft (PDX) models, providing unparalleled expertise and streamlined project management to accelerate drug development. Their intended clients include pharmaceutical companies, hospitals, oncology practices, and patients seeking access to clinical trials. With state-of-the-art facilities and a commitment to operational excellence, they aim to enhance the efficacy of cancer treatments and improve patient outcomes.Explore more
SIC Code 87,873NAICS Code 54,541Show moreXeno START Org Chart
Compare Similar Companies to Xeno START
Compare insights from companies similar to Xeno START, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Xeno START Tech Stack
A closer look at the technologies used by Xeno START
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xeno START
Sign Up For FreeTo access detailed company insights
The START Center for Cancer Research is a global leader in cancer research, dedicated to advancing oncology treatments through its preclinical business, XenoSTART. They offer an extensive collection of over 2,500 high-quality patient-derived xenograft (PDX) models, providing unparalleled expertise and streamlined project management to accelerate dr... Read More